Intra-arterial delivery of bevacizumab after blood-brain barrier disruption for the treatment of recurrent glioblastoma: progression-free survival and overall survival
about
Neurosurgical Techniques for Disruption of the Blood-Brain Barrier for Glioblastoma Treatment.Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide.Predicting and optimizing the territory of blood-brain barrier opening by superselective intra-arterial cerebral infusion under dynamic susceptibility contrast MRI guidanceShort-term clinico-radiographic response to super-selective intra-arterial cerebral infusion of Bevacizumab for the treatment of vestibular schwannomas in Neurofibromatosis type 2Bevacizumab for glioblastoma: current indications, surgical implications, and future directionsAngiopep-2-conjugated poly(ethylene glycol)-co- poly(ε-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats.Angiogenesis in neurological disorders: a review.Update on bevacizumab and other angiogenesis inhibitors for brain cancer.The role of intra-arterial chemotherapy as an adjuvant treatment for glioblastoma.Endovascular superselective treatment of brain tumors: a new endovascular era? A quick review.The role of targeted therapies in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.Emerging insights into barriers to effective brain tumor therapeutics.Use of bevacizumab in recurrent glioblastoma.Transarterial chemoembolization (TACE) for colorectal liver metastases--current status and critical review.New therapeutic strategies regarding endovascular treatment of glioblastoma, the role of the blood-brain barrier and new ways to bypass it.Advances in Molecular Imaging of Locally Delivered Targeted Therapeutics for Central Nervous System Tumors.Selective intra-arterial administration of ¹⁸F-FDG to the rat brain -- effects on hemispheric uptake.Dynamic Susceptibility Contrast-Enhanced MR Perfusion Imaging in Assessing Recurrent Glioblastoma Response to Superselective Intra-Arterial Bevacizumab Therapy.Apparent diffusion coefficient changes predict survival after intra-arterial bevacizumab treatment in recurrent glioblastoma.Metabolic response of glioblastoma to superselective intra-arterial cerebral infusion of bevacizumab: a proton MR spectroscopic imaging study.Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study.Trends in Malignant Glioma Monoclonal Antibody Therapy.Glioblastoma Treatments: An Account of Recent Industrial DevelopmentsReal-Time MRI Guidance for Reproducible Hyperosmolar Opening of the Blood-Brain Barrier in Mice
P2860
Q26801485-8AC55033-E0ED-43FF-A380-B411D4EE8177Q27010580-8124C826-6F1C-4B87-ADF7-8A0074033DB5Q30362270-F7A81A67-C3BA-4A6B-BC7E-C8F93A28E127Q30454047-282D4CBA-7C7A-42A0-90F9-5FD893CA4D1AQ36822207-BEB184E4-F964-4AD8-823F-D98B5BC54B59Q37714094-9A10ECA0-02BD-4A09-91B5-35AD85FC1F56Q38034321-5897E607-DDE9-476F-954E-43ED885BAC7CQ38106370-86A6A9CB-C461-4B64-BCB1-12E95DF3B8FDQ38179019-A6476B89-D4E9-4333-A821-E5FBCE92B61FQ38186612-522C4085-8806-46B8-B3F1-7CE95B0B4269Q38205134-526261FE-2ABA-47A7-9F49-3F10F78104B1Q38237653-4008B66A-C166-4F1E-940F-5357337BAA50Q38438668-B3479F81-2FD2-4DFC-B389-DC8E106733F7Q38531685-C761DA9C-68BD-41C1-9024-1040D3D93C1EQ38626364-6C58C954-9079-4457-AA15-F6D9DFB4F315Q39139224-E64332D7-808B-4E33-85A9-138ACB82751DQ39407470-16EED296-AF34-4667-AB0D-0018028BAF04Q48220641-458B9EC2-1F91-4405-86ED-C727FEBC1643Q48245198-39CF365B-DB04-4ED1-BC8C-DEC160A86F78Q48519374-D0AC8182-6AB6-4481-ABFD-684007BCFCE8Q48858178-8187EB0B-F5E1-4102-A5A7-EAED7658B8FFQ54942652-3024BFA2-3920-40D1-93AC-8C1D4565BD39Q57111067-BA251DEC-73C0-42F6-AF49-7A5776D56043Q58707854-90BC1F99-4707-43BF-803C-31D600101ECF
P2860
Intra-arterial delivery of bevacizumab after blood-brain barrier disruption for the treatment of recurrent glioblastoma: progression-free survival and overall survival
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Intra-arterial delivery of bev ...... survival and overall survival
@ast
Intra-arterial delivery of bev ...... survival and overall survival
@en
Intra-arterial delivery of bev ...... survival and overall survival
@nl
type
label
Intra-arterial delivery of bev ...... survival and overall survival
@ast
Intra-arterial delivery of bev ...... survival and overall survival
@en
Intra-arterial delivery of bev ...... survival and overall survival
@nl
prefLabel
Intra-arterial delivery of bev ...... survival and overall survival
@ast
Intra-arterial delivery of bev ...... survival and overall survival
@en
Intra-arterial delivery of bev ...... survival and overall survival
@nl
P2093
P2860
P1433
P1476
Intra-arterial delivery of bev ...... survival and overall survival
@en
P2093
Apostolos John Tsiouris
Benjamin J Shin
Christoph P Hofstetter
Howard Riina
Jan-Karl Burkhardt
John A Boockvar
Kartik Kesavabhotla
Paul Christos
P2860
P304
P356
10.1016/J.WNEU.2011.05.056
P577
2011-11-21T00:00:00Z